Paksoy provides advice across a broad spectrum of areas including pharmaceuticals, biotechnology, medical devices, nutritional supplements, clinical research and private hospitals.
We assist our clients on a wide range of issues concerning the healthcare and pharmaceuticals sector. We provide guidance from product inception to final marketing and commercialisation of products in Turkey.
We also support our clients in drafting contracts regarding manufacturing and distribution of medical devices and medicinal products, devising and implementing compliance programs, in particular with regard to the promotion, transparency rules and public procurement legislation.
We also have substantial experience of the issues affecting healthcare and pharmaceuticals companies in the context of M&A transactions.
“ Paksoy is one of the few Turkish firms to gain recognition in this specialist area. ”
PLC Which Lawyer
Featured publications
Content not found.
Related contents
1 April 2020
Actions Taken by Pharmaceutical and Medical Device Institution in relation to COVID-19
Significant actions have been taken by the Ministry of Health and the Turkish Pharmaceutical and Medical Device Institution in relation to…
17 February 2020
Paksoy advises Novartis on the sale of Sandoz Turkey’s manufacturing facility to Generica
Novartis, one of the world’s largest pharmaceutical companies, has executed an agreement to sell one of Sandoz Turkey’s manufacturing…